The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBOTT LABS | COM | 002824100 | 2,271,162 | 31,400 | SH | SOLE | 31,400 | 0 | 0 | |||
ABIOMED INC | COM | 003654100 | 4,530,733 | 13,939 | SH | SOLE | 13,939 | 0 | 0 | |||
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 8,403,719 | 232,790 | SH | SOLE | 232,790 | 0 | 0 | |||
AFFIMED N V | COM | N01045108 | 1,044,257 | 335,774 | SH | SOLE | 335,774 | 0 | 0 | |||
ALBIREO PHARMA INC | COM | 01345P106 | 442,251 | 18,029 | SH | SOLE | 18,029 | 0 | 0 | |||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 17,194,969 | 1,263,407 | SH | SOLE | 1,263,407 | 0 | 0 | |||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 601,145 | 62,750 | SH | SOLE | 62,750 | 0 | 0 | |||
ANTHEM INC | COM | 036752103 | 604,049 | 2,300 | SH | SOLE | 2,300 | 0 | 0 | |||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 1,409,747 | 106,880 | SH | SOLE | 106,880 | 0 | 0 | |||
AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 159,229 | 73,717 | SH | SOLE | 73,717 | 0 | 0 | |||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 3,169,400 | 81,371 | SH | SOLE | 81,371 | 0 | 0 | |||
ARGENX SE | SPONSORED ADR | 04016X101 | 3,672,180 | 38,224 | SH | SOLE | 38,224 | 0 | 0 | |||
ARQULE INC | COM | 04269E107 | 954,592 | 344,618 | SH | SOLE | 344,618 | 0 | 0 | |||
ARRAY BIOPHARMA INC | COM | 04269X105 | 1,288,371 | 90,412 | SH | SOLE | 90,412 | 0 | 0 | |||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 955,663 | 15,254 | SH | SOLE | 15,254 | 0 | 0 | |||
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 1,323,149 | 163,959 | SH | SOLE | 163,959 | 0 | 0 | |||
BIOSPECIFICS TECHNOLOGIES CO | COM | 090931106 | 1,333,200 | 22,000 | SH | SOLE | 22,000 | 0 | 0 | |||
CARETRUST REIT INC | COM | 14174T107 | 956,199 | 51,264 | SH | SOLE | 51,264 | 0 | 0 | |||
CENTENE CORP DEL | COM | 15135B101 | 495,790 | 4,300 | SH | SOLE | 4,300 | 0 | 0 | |||
CONFORMIS INC | COM | 20717E101 | 48,993 | 136,851 | SH | SOLE | 136,851 | 0 | 0 | |||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 370,646 | 47,096 | SH | SOLE | 47,096 | 0 | 0 | |||
DANAHER CORP DEL | COM | 235851102 | 4,936,613 | 47,804 | SH | SOLE | 47,804 | 0 | 0 | |||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 1,463,003 | 69,700 | SH | SOLE | 69,700 | 0 | 0 | |||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 439,081 | 41,074 | SH | SOLE | 41,074 | 0 | 0 | |||
ENSIGN GROUP INC | COM | 29358P101 | 3,323,165 | 85,575 | SH | SOLE | 85,575 | 0 | 0 | |||
EPIZYME INC | COM | 29428V104 | 156,766 | 25,449 | SH | SOLE | 25,449 | 0 | 0 | |||
FATE THERAPEUTICS INC | COM | 31189P102 | 2,116,950 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | |||
FLUIDIGM CORP DEL | COM | 34385P108 | 434,922 | 50,455 | SH | SOLE | 50,455 | 0 | 0 | |||
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 1,057,829 | 294,660 | SH | SOLE | 294,660 | 0 | 0 | |||
GENOMIC HEALTH INC | COM | 37244C101 | 1,537,209 | 23,866 | SH | SOLE | 23,866 | 0 | 0 | |||
GLAXOSMITHKLINE PLC | SPONSORED ADR | 37733W105 | 20,391,894 | 529,484 | SH | SOLE | 529,484 | 0 | 0 | |||
ILLUMINA INC | COM | 452327109 | 1,544,040 | 5,148 | SH | SOLE | 5,148 | 0 | 0 | |||
INVACARE CORP | COM | 461203101 | 317,779 | 73,902 | SH | SOLE | 73,902 | 0 | 0 | |||
LOXO ONCOLOGY INC | COM | 548862101 | 1,400,700 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
MERCK & CO INC | COM | 58933Y105 | 3,527,912 | 45,800 | SH | SOLE | 45,800 | 0 | 0 | |||
MYLAN N V | SHS EURO | N59465109 | 1,507,000 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | |||
NATERA INC | COM | 632307104 | 551,964 | 39,539 | SH | SOLE | 39,539 | 0 | 0 | |||
OPIANT PHARMACEUTICALS INC | COM | 683750103 | 200,869 | 13,901 | SH | SOLE | 13,901 | 0 | 0 | |||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 860,825 | 42,301 | SH | SOLE | 42,301 | 0 | 0 | |||
QIAGEN NV | SHS NEW | N72482123 | 1,905,085 | 55,300 | SH | SOLE | 55,300 | 0 | 0 | |||
R1 RCM INC | COM | 749397105 | 18,676,983 | 2,349,306 | SH | SOLE | 2,349,306 | 0 | 0 | |||
RADIUS HEALTH INC | COM NEW | 750469207 | 9,103,354 | 552,053 | SH | SOLE | 552,053 | 0 | 0 | |||
SAGE THERAPEUTICS INC | COM | 78667J108 | 792,279 | 8,271 | SH | SOLE | 8,271 | 0 | 0 | |||
SANOFI | SPONSORED ADR | 80105N105 | 13,293,965 | 306,242 | SH | SOLE | 306,242 | 0 | 0 | |||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 4,419,110 | 40,494 | SH | SOLE | 40,494 | 0 | 0 | |||
SEASPINE HLDGS CORP | COM | 81255T108 | 281,972 | 15,459 | SH | SOLE | 15,459 | 0 | 0 | |||
TELIGENT INC NEW | COM | 87960W104 | 3,079,042 | 2,247,476 | SH | SOLE | 2,247,476 | 0 | 0 | |||
TESARO INC | COM | 881569107 | 2,673,000 | 36,000 | SH | SOLE | 36,000 | 0 | 0 | |||
TG THERAPEUTICS INC | COM | 88322Q108 | 266,500 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | |||
TRICIDA INC | COM | 89610F101 | 955,509 | 40,522 | SH | SOLE | 40,522 | 0 | 0 | |||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 6,047,089 | 36,492 | SH | SOLE | 36,492 | 0 | 0 | |||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 1,294,206 | 205,104 | SH | SOLE | 205,104 | 0 | 0 | |||
ZOGENIX INC | COM NEW | 98978L204 | 20,542,621 | 563,429 | SH | SOLE | 563,429 | 0 | 0 | |||
MYLAN N V | SHS EURO | N59465109 | 4,345,640 | 158,600 | SH | Call | SOLE | 158,600 | 0 | 0 |